Search for: "Myriad Genetics" Results 221 - 240 of 856
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
12 Feb 2015, 5:19 am by Rebecca Tushnet
Myriad Genetics  3:45 - Looking Forward: the Next Ten Years - Peter Jaszi, American University Washington College of Law, Daniela Kraiem, American University Washington College of Law, and community  4:30 – Closehttp://tushnet.blogspot.com/feeds/posts/default? [read post]
10 Feb 2015, 9:59 pm by Patent Docs
With its agreement to dismiss actions (with prejudice) against Ambry Genetics, LabCorp, Invitae, and Pathway Genomics, the earlier settlement agreement reached with Gene-by-Gene... [read post]
30 Jan 2015, 9:34 am by Audrey A Millemann
The plaintiffs were Myriad Genetics, University of Utah, and others. [read post]
29 Jan 2015, 12:30 pm by David Kravets
The Supreme Court in 2013 struck down Myriad Genetics' patents of the human genes BRCA1 and BRCA2. [read post]
27 Jan 2015, 9:59 pm by Patent Docs
Myriad Genetics in 2013, Myriad (paradoxically to those either not paying attention or who over interpreted the scope of the Court's holding in its opinion) filed suit against six genetic diagnostic test providers (Ambry Genetics, Gene-by-Gene, Quest, GeneDx, Invitae, and LabCorp) and was itself sued in declaratory judgment actions by three others (Quest, Invitae, and Counsyl) (see "Myriad Genetics Sues LabCorp over BRCA Gene… [read post]
27 Jan 2015, 6:49 am by Holly Kozlowski
However, just one day later, the joy that many life science patent practitioners felt from the revised guidance was tempered when the Court of Appeals for the Federal Circuit affirmed a district court’s holding of invalidity of several patent claims of Myriad Genetics based on patent subject matter ineligibility. [read post]
20 Jan 2015, 3:33 pm
Myriad Genetics that prompted a controversial concurrence by Justice Scalia. [read post]
20 Jan 2015, 9:04 am by Frank Pasquale
But better understanding of the black box of national security intelligence gathering--and its myriad private contractors' operations--is critical. [read post]
20 Jan 2015, 4:30 am by Lisa Larrimore Ouellette
The Court’s holding in Myriad Genetics appears to follow from that in Chakrabarty.Moreover, gDNA is self-replicating, while cDNA is not. [read post]
11 Jan 2015, 12:25 pm
It could also be argued that our genetic material, and in fact the genetic material of any naturally occurring organism, is part of the commons (see Katpost here about the Nagoya Protocol and ownership of genetic resources). [read post]
2 Jan 2015, 1:42 am by Jani
The ECJ's decision is hugely important in a world-wide context, potentially seeing a precedent which will either hinder or enable other similar jurisdictions to allow or disallow similar patents, even in light of the Myriad Genetics saga in the US. [read post]
28 Dec 2014, 3:08 am
The implications of ‘ownership’ of human genetic sequences is presented as an important issue. [read post]
26 Dec 2014, 10:03 pm
Rather, “Myriad’s principal contribution was uncovering the precise location and genetic sequence of the BRCA[ genes]. [read post]
18 Dec 2014, 11:19 am by Joe Mullin
The patent holder in that case, Myriad Genetics, had patented a test on the BRCA1 and BRCA2 genes. [read post]
17 Dec 2014, 9:59 pm by Patent Docs
Noonan -- In a decision that will surprise no one (written by Judge Dyk, which made the conclusions foregone from the first page of the opinion), the Federal Circuit today affirmed the Utah District Court's decision denying Myriad Genetics' motion for a preliminary injunction in the consolidated Multidistrict Litigation styled In re BRCA1- and BRCA2-based Hereditary Cancer Test Patent Litigation. [read post]
17 Dec 2014, 9:33 am by Dennis Crouch
 Following the decision, several companies – including Ambry – began marketing BRCA genetic testing, and Myriad sued. [read post]